# FDA Enforces DSCSA Compliance

The Food and Drug Administration (FDA) continues to enforce the Drug Supply Chain Security Act (DSCSA), requiring pharmaceutical supply chain stakeholders to implement an electronic, interoperable system for tracing prescription drugs at the package level across the United States. This system mandates maintaining serialized product data, verifying saleable returns, and managing suspect or illegitimate products to enhance patient safety and supply chain security. Notably, small dispensers have an extended exemption deadline until November 27, 2027, providing additional time to comply with serialization and verification requirements.

- Procurement professionals should prioritize sourcing DSCSA-compliant serialization and traceability solutions to meet FDA mandates.
- Contractors and vendors offering electronic tracking, data management, and verification services can expect increased demand from pharmaceutical distributors, wholesalers, and dispensers.
- Organizations operating in key states such as California, New York, Texas, Florida, and Illinois should ensure compliance strategies align with federal DSCSA requirements.
- The extended deadline for small dispensers offers a window for phased implementation but requires proactive planning to avoid non-compliance risks post-November 2027.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** September 18, 2026

### Government Entities
- Food and Drug Administration (FDA)

### Vendors
- Cencora (Provider of DSCSA compliance solutions and support)

### Sources
- [DSCSA Compliance | Cencora](https://www.cencora.com/it/soluzioni/__standard-values/quality-and-regulatory/dscsa-compliance) - Cencora